Hans Peter Muhn

Title: Innovations and Contributions of Hans Peter Muhn

Introduction

Hans Peter Muhn is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for medical applications. With a total of two patents to his name, his work has implications for both oral contraception and the treatment of various medical conditions.

Latest Patents

Muhn's latest patents include the invention of 17-(1'-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives. This invention relates to derivatives that can be used in medicinal products for oral contraception and for treating pre-, peri-, and postmenopausal complaints. The derivatives exhibit progestational properties and may also have antimineralocorticoid and neutral to slightly androgenic actions. Another significant patent involves tetrahydrocarbazole derivatives that serve as ligands for G-protein-coupled receptors (GPCR). These derivatives are particularly effective as antagonists of gonadotropin-releasing hormone (GnRH) and are intended for treating pathologic conditions mediated by GPCR.

Career Highlights

Throughout his career, Hans Peter Muhn has worked with prominent companies in the pharmaceutical industry, including Zentaris AG and Bayer Intellectual Property GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to his successful patent applications.

Collaborations

Muhn has collaborated with notable colleagues such as Marcus Koppitz and Kenneth Jay Shaw. These partnerships have likely contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Hans Peter Muhn's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to have a significant impact on the treatment of various health conditions.